Coadministration of interleukin-6 (IL-6) and soluble IL-6 receptor delays progression of wobbler mouse motor neuron disease

Brain Research

Volumn 726, Issue 1-2, 1996, Pages 91-97

  Ikeda, Ken ^a   Kinoshita, Masao ^a   Tagaya, Nozomu ^a   Shiojima, Toshiya ^a   Taga, Tetsuya ^b   Yasukawa, Kiyoshi ^c   Suzuki, Hideki ^d   Okano, Akira ^d  

^a TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c TOSOH CORPORATION   (Japan)

^d AJINOMOTO CO INC   (Japan)

Author keywords

Ciliary neurotrophic factor; Glycoprotein gp130; Interleukin 6; Interleukin 6 receptor; Leukemia inhibitory factor; Motoneuron disease; Wobbler

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; GLYCOPROTEIN GP 130; INTERLEUKIN 6 RECEPTOR; LEUKEMIA INHIBITORY FACTOR; RECOMBINANT INTERLEUKIN 6;

ANIMAL MODEL; ANTIBODY DETECTION; ARTICLE; BICEPS BRACHII MUSCLE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; GRIP STRENGTH; IMMUNOPHARMACOLOGY; MOTOR NEURON DISEASE; MOUSE; MUSCLE ATROPHY; NEUROLOGIC DISEASE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030575293     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00316-2     Document Type: Article

References (34)

1. [1] Bazan, J.F., Neuropoietic cytokines in the hematopoietic fold, Neuron, 7(1991) 197-208.
2. [2] Bolin, L.M., Verity, A.N., Silver, J.E., Shooter, E.M. and Abrams, J.S., Interleukin-6 production by Schwann cells and induction in sciatic nerve injury, J. Neurochem., 64 (1995) 850-858.
3. [3] Curtis, R., Adryan, K.M., Zhu, Y., Harkness, P.J., Lindsay, R.M. and DiStefano, P.S., Retrograde axonal transport of ciliary neurotrophic factor is increased by peripheral nerve injury, Nature, 365 (1993) 253-255.
4. [4] Curtis, R., Scherer. S.S., Somogyi, R., Adryan, K.M., Ip, N.Y., Zhu, Y., Lindsay, R.M. and DiStefano, P.S., Retrograde axonal transport of LIF is increased by peripheral nerve injury: correlation with increased LIF expression in distal nerve, Neuron, 12 (1994) 191-204.
5. [5] Davis, S., Aldrich, T.H., Stahl, N., Pan, L., Taga, T., Kishimoto, T., Ip, N.Y. and Yancopoulos, G.D., LIFR β and gp 130 as heterodimerizing signal transducers of the tripartite CNTF receptor, Science, 260 (1993) 1805-1808.
6. [6] Dittrich, F., Thoenen, H. and Sendtner, M., Ciliary neurotrophic factor: pharmacokinetics and acute-phase response in rat, Ann. Neurol., 35 (1994) 151-163.
7. [7] Duchen, L.W. and Strich, S.J., An hereditary motor neurone disease with progressive denervation of muscle in the mouse: the mutant 'wobbler', J. Neurol. Neurosurg. Psychiatry, 31 (1968) 535-542.
8. [8] Hama, T., Kushima, Y., Miyamoto, M., Kubota, M., Takei, N. and Hatanaka, H., Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures. Neuroscience, 40 (1991) 445-452.
9. [9] Hilton, D.J., Nicola, N.A., Waring, P.M. and Metcalf, D., Clearance and fate of leukemia-inhibitory factor (LIF) after injection into mice, J. Cell Physiol., 148 (1991) 430-439.
10. [10] Ikeda, K., Iwasaki, Y., Shiojima, T. and Kinoshita, M., Neuroprotective effect of various cytokines on developing spinal motoneurons following axotomy, J. Neurol. Sci., 135 (1996) 109-113.
11. [11] Ikeda, K., Iwasaki, Y., Tagaya, N., Shiojima, T. and Kinoshita, M., Neuroprotective effect of cholinergic differentiation factor/leukemia inhibitory factor (CDF/LIF) on wobbler murine motor neuron disease. Muscle Nerve, 18 (1995) 1344-1347.
12. [12] Ikeda, K., Kinoshita, M., Iwasaki, Y., Tagaya, N. and Shiojima, T., Lecithinized superoxide dismutase retards wobbler mouse motoneuron disease, Neuromusc. Disord., 5 (1995) 383-390.
13. [13] Ikeda, K., Klinkosz, B., Greene, T., Cedarbaum, J.M., Wong, V., Lindsay, R.M. and Mitsumoto, H., Effects of brain-derived neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease. Ann. Neurol., 37 (1995) 505-511.
14. [14] Ikeda, K., Wong, V., Holmlund, T.H., Greene, T., Cedarbaum, J.M., Lindsay, R.M. and Mitsumoto, H., Histometric effects of ciliary neurotrophic factor in wobbler mouse motor neuron disease, Ann. Neurol., 37 (1995) 47-54.
15. [15] Kiefer, R., Lindholm, D. and Kreutzberg, G.W., Interleukin-6 and transforming growth factor-β1 mRNAs are induced in rat facial nucleus following motoneuron axotomy, Eur. J. Neurosci., 5 (1993) 775-781.
16. [16] Kishimoto, T., Arika, S. and Taga, T., Interleukin-6 and its receptor: a paradigm for cytokines, Science, 258 (1992) 593-597.
17. [17] Kishimoto, T., Taga, T. and Arika, S., Cytokine signal transduction, Cell, 76 (1994) 253-262.
18. [18] Kushima, Y. and Hatanaka, H., Interleukin-6 and leukemia inhibitory factor promote the survival of acetylcholinesterase-positive neurons in culture from embryonic rat spinal cord, Neurosci. Lett., 143 (1992) 110-114.
19. [19] Matsuda, T., Hirano, T. and Kishimoto, T., Establishment of an interleukin-6 (IL 6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL 6 monoclonal antibodies. Eur. J. Immunol., 18 (1988) 951-956.
20. [20] Mitsumoto, H. and Bradley, W.G., The wobbler mouse: the murine motor neuron disease: degeneration and regeneration of the lower motor neuron, Brain, 105 (1982) 811-834.
21. [21] Mitsumoto, H., Ikeda, K., Holmlund, T., Greene, T., Cedarbaum, J.M., Wong, V. and Lindsay. R.M., The effect of ciliary neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease, Ann. Neurol., 36 (1994) 142-148.
22. [22] Mitsumoto, H., Ikeda, K., Klinkosz, B., Cedarbaum, J.M., Wong, V. and Lindsay, R.M., Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF, Science, 265 (1994) 1107-1110.
23. [23] Murakami, M., Hibi, M., Nakagawa, N., Nakagawa, T., Yasukawa, K., Yamanishi, K., Taga, T. and Kishimoto, T., IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase, Science, 260 (1993) 1808-1810.
24. [24] Narazaki, M., Yasukawa, K., Saito, T., Ohsugi, Y., Fukui, H., Koishihara, Y., Yancopoulos, G.D., Taga, T. and Kishimoto, T., Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130, Blood, 82 (1993) 1120-1126.
25. [25] Sugita, T., Totsuka, T., Saito, M., Yamasaki, K., Taga, T., Hirano, T. and Kishimoto, T., Functional murine interleukin 6 receptor with the intracisternal A particle gene product at its cytoplasmic domain: its possible role in plasmacytomagenesis, J. Exp. Med., 171 (1990). 2001-2009.
26. [26] Suzuki, H., Yasukawa, K., Saito, T., Narazaki, M., Hasegawa, A., Taga, T. and Kishimoto, T., Serum soluble IL-6 receptor in MRL/lpr mice is elevated with age and mediates the IL-6 signal, Eur. J. Immunol., 23 (1993) 1078-1082.
27. [27] Taga, T. and Kishimoto, T., Cytokine receptors and signal transduction, FASEB J., 6 (1992) 3387-3396.
28. [28] Taga, T. and Kishimoto, T., Signaling mechanisms through cytokine receptors that share signal transducing receptor components, Curr. Opin. Immunol., 7 (1995) 17-23.
29. [29] Taga, T., Narazaki, M., Yasukawa, K., Saito, T., Miki, D., Hamaguchi, M., Davis, S., Shoyab, M., Yancopoulos, G.D. and Kishimoto, T., Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130, Proc. Natl. Acad. Sci. USA, 89 (1992) 10998-11001.
30. [30] Takatsuki, F., Okano, A., Suzuki, C., Miyasaka, Y., Hirano, T., Kishimoto, T., Ejima, D. and Akiyama, Y., Interleukin 6 perfusion stimulates reconstitution of the immune and hematopoietic systems after 5-fluorouracil treatment, Cancer Res., 50 (1990) 2885-2890.
31. [31] Voller, A., Bidwell, D.E. and Bartlett, A., Enzyme immunoassay in diagnostic medicine, Bull. W.H.O., 53 (1976) 55-65.
32. [32] Yasueda, H., Nagase, K., Hosoda, A., Akiyama, Y. and Yamada, K., High-level direct expression of semi-synthetic human interleukin-6 in Escherichia coli and production of N-terminus Met-free product, Biotechnology, 8 (1990) 1036-1040.
33. [33] Yasukawa, K., Saito, T., Fukunaga, T., Sekimori, Y., Koishihara, Y., Fukui, H., Ohsugi, Y., Matsuda, T., Yawata, H., Hirano, T., Taga, T. and Kishimoto, T., Purification and characterization of soluble human IL-6 receptor expressed in CHO cells, J. Biochem., 108 (1990) 673-676.
34. [34] Yoshida, K., Chambers, I., Nichols, J., Smith, A., Saito, M., Yasukawa, K., Shoyab, M., Taga, T. and Kishimoto, T., Maintenance of the pluripotential phenotype of embryonic stem cells through direct activation of gp130 signalling pathways, Mech. Dev., 45 (1994) 163-171.